Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: Clinical implications

Cellular Oncology

Volumn 37, Issue 1, 2014, Pages 1-8

  Yiannakopoulou, Eugenia ^a  

^a UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

Familial breast cancer; Hereditary breast cancer; Mendelian inheritance; Polygenic inheritance

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; FEMALE; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; MUTATION; RISK FACTORS;

EID: 84894457154     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-013-0158-0     Document Type: Review

References (83)

1. J.C. Carroll, C. Cremin, J. Allanson, S.M. Blaine, H. Dorman, C.A. Gibbons et al., Hereditary breast and ovarian cancers. Can. Fam. Physicians 54, 1691-1692 (2008)
2. S.E. Filippini, A. Vega, Breast cancer genes: beyond BRCA1 and BRCA2. Front. Biosci. (Landmark Ed). 18, 1358-1372 (2013)
3. M.E. Robson, Treatment of hereditary breast cancer. Semin. Oncol. 34, 389-391 (2007)
4. T. Ripperger, D. Gadzicki, A. Meindl, B. Schlegelberger, Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur. J. Hum. Genet. 17, 722-731 (2009)
5. A. Osorio, A. Barroso, B. Martínez, A. Cebrián, J.M. San Román, F. Lobo et al., Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br. J. Cancer 82, 1266-1270 (2000) (Pubitemid 30145343)
6. R. Sabatier, J. Adélaïde, P. Finetti, A. Ferrari, L. Huiart, H. Sobol et al., BARD1 homozygous deletion, a possible alternative to BRCA1 mutation in basal breast cancer. Genes, Chromosomes Cancer 49, 1143-1151 (2010)
7. M.A. Didraga, E.H. van Beers, S.A. Joosse, K.I. Brandwijk, R.A. Oldenburg, L.F. Wessels et al., A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients. Breast Cancer Res. Treat. 130, 425-436 (2011)
8. C.I. Szabo, M.C. King, Population genetics of BRCA 1 and BRCA2. Am. J. Hum. Genet. 60, 1013-1020 (1997)
9. D. Ford, D.F. Easton, M. Stratton, S. Narod, D. Goldgar, P. Devilee et al., Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 62, 676-689 (1998) (Pubitemid 28164626)
10. K.E. Malone, J.R. Daling, J.D. Thompson, C.A. O'Brien, L.V. Francisco, E.A. Ostrander, BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history. JAMA 279, 922-929 (1998) (Pubitemid 28136081)
11. K.L. Nathanson, B.L. Weber, "Other" breast cancer susceptibility genes: searching for more holy grail. Hum. Mol. Genet. 10, 715-720 (2001) (Pubitemid 32331580)
12. C. Turnbull, N. Rahman, Genetic predisposition to breast cancer: past, present, and future. Annu. Rev. Genomics Hum. Genet. 9, 321-345 (2008)
13. F.P. Li, J.F. Fraumeni Jr., Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome? Ann. Intern. Med. 71, 747-752 (1969)
14. J.M. Birch, Li Fraumeni Syndrome. Eur. J. Cancer 30A, 1935-1941 (1994) (Pubitemid 24382591)
15. R.A. Eeles, Germline mutations in the TP53 gene. Cancer Surv. 25, 101-124 (1995) (Pubitemid 26065308)
16. E.I. Palmero, M.I. Achatz, P. Ashton-Prolla, M. Olivier, P. Hainaut, Tumor protein 53 mutations and inherited cancer: beyond Li-Fraumeni syndrome. Curr. Opin. Oncol. 22, 64-69 (2010)
17. S. Tutluer, M.D. Tanriover, G.S. Guven, Cowden syndrome: a major indication for extensive cancer surveillance. Med. Oncol. 29, 1365-1368 (2012)
18. J.A. Hobert, C. Eng, PTEN hamartoma tumor syndrome: an overview. Genet. Med. 11, 687-694 (2009)
19. G.M. Blumenthal, P.A. Dennis, PTEN hamartoma tumor syndromes. Eur. J. Hum. Genet. 16, 1289-1300 (2008)
20. S. Gustafson, K.M. Zbuk, C. Scacheri, C. Eng, Cowden syndrome. Semin. Oncol. 34, 428-434 (2007) (Pubitemid 47503276)
21. R.M. Cisco, J.M. Ford, J.A. Norton, Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer 113(7Suppl), 1850-1856 (2008)
22. K.F. Becker, M.J. Atkinson, U. Reich, I. Becker, H. Nekarda, J.R. Siewert et al., E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54, 3845-3852 (1994) (Pubitemid 24241205)
23. G. Keller, H. Vogelsang, I. Becker, J. Hutter, K. Ott, S. Candidus et al., Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am. J. Pathol. 155, 337-342 (1999) (Pubitemid 29370383)
24. R.C. Fitzgerald, R. Hardwick, D. Huntsman, F. Carneiro, P. Guilford, V. Blair et al., Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J. Med. Genet. 47, 436-444 (2010)
25. C. Caldas, F. Carneiro, H.T. Lynch, J. Yokota, G.L. Wiesner, S.M. Powell et al., Familial gastric cancer: overview and guidelines for management. J. Med. Genet. 36, 873-880 (1999) (Pubitemid 30003842)
26. D. Taheri, N. Afshar-Moghadam, P. Mahzoni, A. Eftekhari, S.M. Hashemi, M.H. Emami et al., Cancer problem in Peutz-Jeghers syndrome. Adv. Biomed. Res. (2013). doi: 10.4103/2277-9175.109721
27. L.A. Boardman, S.N. Thibodeau, D.J. Schaid, N.M. Lindor, S.K. McDonnell, L.J. Burgart et al., Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann. Intern. Med. 128, 896-899 (1998) (Pubitemid 28289483)
28. S. Matsuoka, M. Huang, S.J. Elledge, Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. Science 282, 1893-1897 (1998) (Pubitemid 28555269)
29. M. Weischer, S.E. Bojesen, A. Tybjaerg-Hansen, C.K. Axelsson, B.G. Nordestgaard, Increased risk of breast cancer associated with CHEK2*1100delC. J. Clin. Oncol. 25, 57-63 (2007) (Pubitemid 350003051)
30. C. Cybulski, D. Wokołorczyk, T. Huzarski, T. Byrski, J. Gronwald, B. Górski et al., A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland. Breast Cancer Res. Treat. 102, 119-122 (2007) (Pubitemid 46294966)
31. A. Desrichard, Y. Bidet, N. Uhrhammer, Y.J. Bignon, CHEK2 contribution to hereditary breast cancer in non-BRCA families. Breast Cancer Res. 13, R119 (2011)
32. S.A. Narod, Testing for CHEK2 in the cancer genetics clinic: ready for prime time? Clin. Genet. 78, 1-7 (2010)
33. M. Weischer, S.E. Bojesen, C. Ellervik, A. Tybjaerg-Hansen, B.G. Nordestgaard, CHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controls. J. Clin. Oncol. 26, 542-548 (2008) (Pubitemid 351264346)
34. Y. Shiloh, ATM: ready, set, go. Cell Cycle 2, 116-117 (2003)
35. A. Mavrou, G.T. Tsangaris, E. Roma, A. Kolialexi, The ATM gene and ataxia telangiectasia. Anticancer Res. 28, 401-405 (2008) (Pubitemid 351362844)
36. S. Angèle, J. Hall, The ATM gene and breast cancer: is it really a risk factor? Mutat. Res. 462, 167-178 (2000) (Pubitemid 30190224)
37. J. Hall, The Ataxia-telangiectasia mutated gene and breast cancer: gene expression profiles and sequence variants. Cancer Lett. 227, 105-114 (2005) (Pubitemid 41169924)
38. A. Renwick, D. Thompson, S. Seal, P. Kelly, T. Chagtai, M. Ahmed et al., ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet. 38, 873-875 (2006) (Pubitemid 44141653)
39. F. Lalloo, D.G. Evans, Familial breast cancer. Clin Genet. 82, 105-114 (2012)
40. K.M. Mahdi, M.R. Nassiri, K. Nasiri, Hereditary genes and SNPs associated with breast cancer. Asian Pac. J. Cancer Prev. 14, 3403-3409 (2013)
41. N. Rahman, R.H. Scott, Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players. Hum. Mol. Genet. 16, R60-R66 (2007) (Pubitemid 47241843)
42. N. Rahman, S. Seal, D. Thompson, P. Kelly, A. Renwick, A. Elliott et al., PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet. 39, 165-167 (2007) (Pubitemid 46184346)
43. M.F. Lavin, ATM and the Mre11 complex combine to recognize and signal DNA double-strand breaks. Oncogene 26, 7749-7758 (2007) (Pubitemid 350242462)
44. J.H. Lee, T.T. Paull, ATM activation by DNA double-strand breaks through the Mre11-Rad50-Nbs1 complex. Science 308, 351-354 (2005)
45. H.M. Hsu, H.C. Wang, S.T. Chen, G.C. Hsu, C.Y. Shen, J.C. Yu, Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex. Cancer Epidemiol. Biomarkers Prev. 16, 2024-2032 (2007) (Pubitemid 47621176)
46. N. Bogdanova, S. Feshchenko, P. Schürmann, R. Waltes, B. Wieland, P. Hillemanns et al., Nijmegen Breakage Syndrome mutations and risk of breast cancer. Int. J. Cancer 122, 802-806 (2008)
47. P. van der Groep, E. van der Wall, P.J. van Diest, Pathology of hereditary breast cancer. Cell Oncol. 34, 71-88 (2011)
48. M.J. Ligtenberg, R.P. Kuiper, T.L. Chan, M. Goossens, K.M. Hebeda, M. Voorendt et al., Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat. Genet. 41, 112-117 (2009)
49. A.K. Win, N.M. Lindor, I. Winship, K.M. Tucker, D.D. Buchanan, J.P. Young et al., Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J. Natl. Cancer Inst. 105, 274-279 (2013)
50. S. Shanley, C. Fung, J. Milliken, J. Leary, R. Barnetson, M. Schnitzler et al., Breast cancer immunohistochemistry can be useful in triage of some HNPCC families. Fam. Cancer 8, 251-255 (2009)
51. Y.M. Hendriks, A. Wagner, H. Morreau, F. Menko, A. Stormorken, F. Quehenberger et al., Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology 127, 17-25 (2004) (Pubitemid 38962270)
52. S.A. Madanikia, A. Bergner, X. Ye, J.O. Blakeley, Increased risk of breast cancer in women with NF1. Am. J. Med. Genet. A 158A, 3056-3060 (2012)
53. X. Wang, A.M. Levin, S.E. Smolinski, F.D. Vigneau, N.K. Levin, M.A. Tainsky, Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area. Am. J. Med. Genet. A 158A, 3061-3064 (2012)
54. S. Sharif, A. Moran, S.M. Huson, R. Iddenden, A. Shenton, E. Howard et al., Women with neurofibromatosis 1 are at a moderately increased risk of developing breast cancer and should be considered for early screening. J. Med. Genet. 44, 481-484 (2007) (Pubitemid 47325733)
55. D. Easton, K.A. Pooley, A.M. Dunning, P.D. Pharoah, D. Thompson, D.G. Ballinger et al., Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447, 1087-1093 (2007) (Pubitemid 47014426)
56. R. Gramling, T.L. Lash, K.J. Rothman, H.J. Cabral, R. Silliman, M. Roberts et al., Family history of later-onset breast cancer, breast healthy behavior and invasive breast cancer among postmenopausal women: a cohort study. Breast Cancer Res. 12, R82 (2010)
57. C. Turnbull, S. Ahmed, J. Morrison, D. Pernet, A. Renwick, M. Maranian et al., Genome-wide association study identifies five new breast cancer susceptibility loci. Nat. Genet. 42, 504-507 (2010)
58. S. Wacholder, P. Hartge, R. Prentice, M. Garcia-Closas, H.S. Feigelson, W.R. Diver et al., Performance of common genetic variants in breast-cancer risk models. N. Engl. J. Med. 362, 986-993 (2010)
59. D.F. Conrad, D. Pinto, R. Redon, L. Feuk, O. Gokcumen, Y. Zhang et al., Origins and functional impact of copy number variation in the human genome. Nature 464, 704-712 (2010)
60. P. Stankiewicz, J.R. Lupski, Structural variation in the human genome and its role in disease. Annu. Rev. Med. 61, 437-455 (2010)
61. A.C. Krepischi, M.I. Achatz, E.M. Santos, S.S. Costa, B.C. Lisboa, H. Brentani et al., Germline DNA copy number variation in familial and early-onset breast cancer. Breast Cancer Res. 14, R24 (2012)
62. T. Kouzarides, Chromatin modifications and their function. Cell 128, 693-705 (2007) (Pubitemid 46273577)
63. A.P. Feinberg, R. Ohlsson, S. Henikoff, The epigenetic progenitor origin of human cancer. Nat. Rev. Genet. 7, 21-33 (2006) (Pubitemid 41828945)
64. A. de Bustros, B.D. Nelkin, A. Silverman, G. Ehrlich, B. Poiesz, S.B. Baylin, The short arm of chromosome 11 is a "hot spot" for hypermethylation in human neoplasia. Proc. Natl. Acad. Sci. U. S. A. 85, 5693-5697 (1988)
65. M.J. Kempers, R.P. Kuiper, C.W. Ockeloen, P.O. Chappuis, P. Hutter, N. Rahner et al., Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study. Lancet Oncol. 12, 49-55 (2011)
66. T. Hansmann, G. Pliushch, M. Leubner, P. Kroll, D. Endt, A. Gehrig et al., Constitutive promoter methylation of BRCA1 and RAD51C in patients with familial ovarian cancerand early-onset sporadic breast cancer. Hum. Mol. Genet. 21, 4669-4679 (2012)
67. M.P. Hitchins, Inheritance of epigenetic aberrations (constitutional epimutations) in cancer susceptibility. Adv. Genet. 70, 201-243 (2010)
68. J.M. Flanagan, S. Cocciardi, N. Waddell, C.N. Johnstone, A. Marsh, S. Henderson et al., DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. Am. J. Hum. Genet. 86, 420-433 (2010)
69. M. Esteller, M.F. Fraga, M. Guo, J. Garcia-Foncillas, I. Hedenfalk, A.K. Godwin et al., DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum. Mol. Genet. 10, 3001-3007 (2001) (Pubitemid 34083486)
70. N. Loman, A. Bladström, O. Johannsson, A. Borg, H. Olsson, Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res. 5, R175-R186 (2003)
71. R. Scully, Role of BRCA gene dysfunction in breast and ovarian cancer predisposition. Breast Cancer Res. 2, 324-330 (2000) (Pubitemid 32223614)
72. T. Tapia, S.V. Smalley, P. Kohen, A. Muñoz, L.M. Solis, A. Corvalan et al., Promoter hypermethylation of BRCA1 correlates with absence of expression in hereditary breast cancer tumors. Epigenetics 3, 157-163 (2008)
73. E. Honrado, A. Osorio, R.L. Milne, M.F. Paz, L. Melchor, A. Cascón et al., Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod. Pathol. 20, 1298-1306 (2007) (Pubitemid 350126855)
74. I. Hedenfalk, D. Duggan, Y. Chen, M. Radmacher, M. Bittner, R. Simon et al., Gene-expression profiles in hereditary breast cancer. N. Engl. J. Med. 344, 539-548 (2001) (Pubitemid 32167867)
75. A.M. Dworkin, A.D. Spearman, S.Y. Tseng, K. Sweet, A.E. Toland, Methylation not a frequent "second hit" in tumors with germline BRCA mutations. Fam. Cancer 8, 339-346 (2009)
76. K. Hemminki, B. Chen, Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. Prostate 65, 188-194 (2005) (Pubitemid 41362286)
77. M.P. Zeegers, L.J. Schouten, R.A. Goldbohm, P.A. van den Brandt, A compendium of familial relative risks of cancer among first degree relatives: a population-based study. Int. J. Cancer 123, 1664-1673 (2008)
78. A. Valeri, G. Fournier, V. Morin, J.F. Morin, E. Drelon, P. Mangin et al., Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int. J. Cancer 86, 883-887 (2000) (Pubitemid 30350207)
79. A. Kong, V. Steinthorsdottir, G. Masson, G. Thorleifsson, P. Sulem, S. Besenbacher et al., Parental origin of sequence variants associated with complex diseases. Nature 462, 868-874 (2009)
80. M. Tuna, M. Smid, J.W. Martens, J.A. Foekens, Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancer. Breast Cancer Res. Treat. 132, 189-196 (2012)
81. C. Ellberg, G. Jönsson, H. Olsson, Can a phenotype for recessive inheritance in breast cancer be defined? Fam. Cancer 9, 525-530 (2010)
82. U. Güth, D. Müller, D.J. Huang, E. Obermann, H. Müller, Strictly defined familial male breast cancer. Fam. Cancer 10, 73-77 (2011)
83. G. Bostean, C.M. Crespi, W.J. McCarthy, Associations among family history of cancer, cancer screening and lifestyle behaviors: a population-based study. Cancer Causes Control 24, 1491-1503 (2013)